AstraZeneca
AstraZeneca rejects the latest, and likely the last, takeover price from Pfizer, close to 70 billion pounds or US$118 billion.
Sources: Reuters
Sources: Reuters
Supreme Leader Ali Khamenei calls for a ban on the American Pfizer and British AstraZeneca vaccines.
Swissmedic approves the authorization of the Pfizer-BioNTech vaccine for use in Switzerland.
American pharmaceutical company Pfizer announces plans to acquire Hospira at a cost of $17 billion.
Drugmaker Pfizer says it will not proceed with its attempted $119 billion bid for AstraZeneca.